Positive Phase 3 outcomes would be a prerequisite for any future regulatory submission to the MHRA for a marketing authorisation
While such medications are typically recommended for morbidly obese individuals, in India, film stars and affluent individuals are already using them
David: What would you consider is the platform that has taken you and Novo Nordisk from Liraglutide to Semiglutide to beyond

Essential documentation elements include: Confirmed diagnosis of type 2 diabetes mellitus with supporting evidence (HbA1c results, glucose monitoring data) Detailed description of neuropathic symptoms, including location, character, severity, and temporal pattern Findings from neurological examination, particularly sensory testing using 10-g monofilament, vibration perception (128-Hz tuning fork), and ankle reflexes Specification of neuropathy type (e.g., distal symmetric polyneuropathy, autonomic neuropathy, mononeuropathy) Foot risk stratification according to NICE NG19 criteria (low risk, moderate risk, high risk, active diabetic foot problem) Results from diagnostic investigations such as nerve conduction studies when performed for atypical or uncertain cases Documentation of any functional impairment or complications arising from neuropathy Clinicians should avoid vague terminology such as 'possible neuropathy' or 'neuropathic symptoms' without clear diagnostic confirmation

She has won 16 Grammy Awards
A Novo Nordisk spokesperson told Vox, Novo Nordisk does our best to ensure patients and health care providers are educated about the appropriate and responsible use of our medicines